TABLE 2.
Net Change in Medication Use From Admission to Dischargea
| Virtual Care Team Guided Strategy (n = 106 Encounters) | Usual Care (n = 143 Encounters) | % Change Admission to Discharge | P Value for Between-Arm Difference | ||||
|---|---|---|---|---|---|---|---|
| Admission | Discharge | Admission | Discharge | Intervention | Usual Care | ||
| Beta-blocker | 75 (70.8) | 99 (93.4) | 107 (74.8) | 118 (82.5) | +22.6 | +7.7 | 0.008 |
| ACE inhibitor/ARB | 48 (45.3) | 50 (47.2) | 60 (42.0) | 51 (35.7) | +1.9 | −6.3 | 0.14 |
| ARNI | 22 (20.8) | 26 (24.5) | 5 (3.5) | 12 (8.4) | +3.8 | +4.9 | 0.75 |
| MRA | 33 (31.1) | 52 (49.1) | 22 (15.4) | 30 (21.0) | +17.9 | +5.6 | 0.024 |
| SGLT2i | 26 (24.5) | 34 (32.1) | 13 (9.1) | 22 (15.4) | +7.5 | +6.3 | 0.78 |
Values are n (%) unless otherwise indicated.
a
Excluded 3 encounters of in-hospital deaths (because discharge guideline-directed medical therapy could not be determined in those individuals).
ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; ARNI = angiotensin receptor–neprilysin inhibitor; MRA = mineralocorticoid receptor antagonist; SGLT2i = sodium-glucose cotransporter-2 inhibitor.